disCase vs COPD Advances

disCase app is created to Educate, Empower, and Engage doctors in clinical practice Description: Continuing the efforts to improve the standard of diabetes care in World, disCase app is a trusted and reliable source to help clinical practitioner in their clinical practice. disCase app trusted content was developed with healthcare professionals (HCP) in mind and provide streamlined functionality and access to Continuing Medical Education (CME) content. The module contents are endorsed by Reputed Medical schools across globe. App features: • Streamlined functionality and easy navigation to each of the content repository • Access to modules • Case study content with schedule option for group and one to one discussion with subject expert. • Persistent login, so you need to log into the app only once • Interactive quizzes and polls • Insulin Initiation Kit • Resources • Chatbot

In the management of chronic obstructive pulmonary disorder (COPD), several therapeutic mechanisms have been developed. These therapies include monoclonal antibodies that target pro-inflammatory alarmins and associated cytokine pathways. With continued developments in COPD management, biologic therapies are a promising strategy to achieve treatment goals with promising data showing potential for improving outcomes in patient care.